Connexall published a first human trial showing that Experimental One-Dose Treatment cuts bad cholesterol by 52% in the first trial.

Established more than 30 years ago by a forward-thinking leader, Connexall remains a cornerstone in integrated healthcare. Connexall forms lasting relationships with healthcare institutions of various sizes and specialties, offering tailored solutions for their unique requirements. Rather than merely adapting to technological changes, the aim is to set new benchmarks in quality of care, patient experience, and staff satisfaction. In Connexall's ongoing quest for innovation, the company designs, fine-tunes, and rolls out specialized solutions that enable healthcare professionals to excel in their roles. The Connected Hospital model stands as a testament to this dedication, seamlessly weaving together people, tasks, and devices into a cohesive, intuitive platform. This transformative approach streamlines workflow, enhances team collaboration, and cultivates a secure, healing atmosphere. The comprehensive strategy not only boosts the efficiency of healthcare delivery but also infuses it with empathy and attentiveness, thereby fostering an environment that is both secure and conducive to healing.

Founded 1992